20065 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Sub-classes:COMPOSITIONS AND METHODS FOR GENOME EDITING
#2HYBRID BIOLOGICAL MEMBRANES, METHODS OF MAKING AND USES THEREOF
#3COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION
#4mRNA COMPOSITION FOR TREATING CANCER, PREPARATION CONTAINING THE SAME AND USE THEREOF
#5LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF
#6Multilamellar Vesicles and Methods and Uses Thereof
#7LIPOSOME COMPOSITIONS COMPRISING WEAK ACID DRUGS AND USES THEREOF
#8PRE-MEDICATION AND IMPROVED TREATMENT REGIMEN
#9LIPOSOME COMPOSITIONS FOR DELIVERY OF COMPOUNDS AND METHODS THEREOF
#10GAMMA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#11BIPHASIC CHRONO-ADAPTIVE NUTRACEUTICAL SYSTEM FOR ENHANCED CIRCADIAN BIOAVAILABILITY
#12IONIZABLE CATIONIC LIPIDS
#13USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS
#14LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
#15SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS
#16LIPID NANOPARTICLES
#17COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND/OR CARDIOVASCULAR DISEASE
#18LIPOSOMAL FORMULATIONS OF BCL INHIBITORS
#19POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#20POLYOXYALKYLENE-1,2-DIMYRISTOYL-GLYCEROL COMPOUNDS, WHEREIN THE POLYOXYALKYLENE IS A POLY(ETHYLENE OXIDE) HAVING C1 TO C3-ALKYLOXYMETHYL SIDE CHAINS
#21NUCLEIC ACID VACCINES
#22COMPOSITIONS AND METHODS FOR GENOME EDITING
#23OXAZOLIDINONE LIPOSOME COMPOSITIONS
#24COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#25LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES
#26Compositions for Drug Delivery and Methods of Use Thereof
#27GENE DELIVERY AGENTS
#28NEBULIZER KITS AND USES THEREOF
#29LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF
#30NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME
#31LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES
#32Compositions for Drug Delivery and Methods of Use Thereof
#33ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF
#34GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF
#35KAEMPFEROL BIOMIMETIC NANO-MATERIAL, METHOD FOR PREPARING SAME AND USE THEREOF
#36METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
#37NANODELIVERY SYSTEMS FOR EXTENDED RELEASE OF ANTIBODIES
#38METAL-CHELATED POLYPHENOL COMPLEX NANOPARTICLE, DRUG-LIPID PARTICLE, PREPARATION METHODS FOR THE SAME, AND USES THEREOF
#39ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#40Synthetic Nanostructures Including Nucleic Acids and/or Other Entities
#41LIPID FUSION DEPOT COMPOSITION WITH CONTROLLED INITIAL RELEASE, AND METHOD FOR PREPARING SAME
#42Poxvirus mRNA Vaccine and Use
#43POLYNUCLEOTIDE ENCAPSULATION AND PRESERVATION USING SELF-ASSEMBLING MEMBRANES
#44USE OF MITOXANTRONE LIPOSOME IN COMBINATION WITH CAPECITABINE IN TREATING NASOPHARYNGEAL CARCINOMA
#45CONTINUOUS FLOW METHODS FOR PRODUCING MANNOSE-1-PHOSPHATE, POLYMORPHS OF MANNOSE-1-PHOSPHATE, AND COMPOSITIONS AND USES RELATED THERETO
#46CAROTENOID COMPOSITIONS AND USES THEREOF
#47COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
#48NOVEL METHODS TO ENHANCE GENE DELIVERY
#49SURFACE PEGYLATED SOLID LIPID NANOCARRIER DUALLY LOADED WITH ATAZANAVIR AND ELVITEGRAVIR FOR COMBINATION ANTIRETROVIRAL THERAPY
#50IONIZABLE LIPID CONTAINING BIODEGRADABLE ESTER BOND AND LIPID NANOPARTICLES COMPRISING SAME
#51NUCLEIC ACID DRUG FOR TREATING HYPERURICEMIA-RELATED DISEASES, PREPARATION METHOD THEREFOR, AND USE THEREOF
#52SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS
#53NANOMATERIALS
#54Methods For Treating Pancreatic Cancer Using Combination Therapies
#55COMPOSITIONS AND METHODS FOR ADMINISTERING ANESTHETICS
#56LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT
#57PROSTAGLANDIN ANALOGS AND METHODS FOR SUSTAINED GLAUCOMA MANAGEMENT
#58AAV PIGGYBAC TRANSPOSON POLYNUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREFOR
#59Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#60CURCUMIN COMPOUND COMPOSITION
#61MULTI-TAIL TYPE IONIZABLE LIPID, PREPARATION METHOD THEREFOR AND USE THEREOF
#62mRNA LIPID NANOPARTICLES FOR THE TREATMENT OF NIEMANN-PICK TYPE C DISEASE
#63PERIPHERALIZATION OF CENTRALLY-ACTING CANNABINOID-1 RECEPTOR ANTAGONISTS BY NANOPARTICLES FOR THE TREATMENT METABOLIC RELATED CONDITIONS
#64LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF
#65MULTI-SPECIFIC REAGENT FOR TARGETED DELIVERY OF LIPID NANOPARTICLES
#66THERAPEUTIC FOR CANCER REFRACTORY TO IMMUNE CHECKPOINT INHIBITOR
#67LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF
#68FUSOGENIC LIPID NANOPARTICLES AND METHODS FOR THE MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE
#69Ionizable Liposome, Preparation Thereof, and Application Thereof in Gene Delivery
#70USE OF TRANSMEMBRANE PH GRADIENT LIPOSOMES FOR TREATING HYPERAMMONEMIC CRISIS ASSOCIATED WITH INBORN ERRORS OF METABOLISM
#71NOVEL TARGETS AGAINST OVARIAN CANCER
#72INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)
#73IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA
#74NOVEL RNA CONSTRUCT AND METHODS OF USE THEREOF FOR ENHANCING THE THERAPEUTIC EFFECTS OF CYTOTOXIC CELLS AND STEM CELLS
#75ON-DEMAND RELEASE OF ANTIBIOTIC COMPOSITION AND METHOD FOR TREATING INFECTIONS
#76Compositions of Phosphorylated Tau Peptides and Uses Thereof
#77COMPOSITIONS AND METHODS FOR EDITING A TRANSTHYRETIN GENE
#78Lipid Nanoparticle Compositions and Methods For Formulating Insoluble Drugs
#79ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#80COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF
#81TARGETED NANOPARTICLES AND THEIR USES RELATED TO INFECTIOUS DISEASE
#82Formulated and/or Co-Formulated Liposome Compositions Containing IDO Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof
#83PEGYLATED LIPOSOMES AND USES THEREOF
#84COMPLEX LIPID NANOPARTICLES ENCAPSULATING POLYPEPTIDES AND USES THEREOF
#85PRODUCTION OF RNA POLYNUCLEOTIDES ENCODING PICORNAVIRUS
#86COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
#87POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF
#88Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#89NANOTUBE-VESICLE COMPOSITIONS AND USES THEREOF
#90LIPID COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY
#91COMBINED MEDICINAL DRUG INCLUDING LIPOSOME COMPOSITION ENCOMPASSING TOPOTECAN OR SALT THEREOF AND DNA DAMAGE REPAIR INHIBITOR
#92IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF
#93LITHE LIPOSOMES COMPRISING ABSORPTION ENHANCERS FOR ORAL DRUG DELIVERY
#94Ribonucleic Acids With 4'-Thio-Modified Nucleotides and Related Methods
#95TRIPTOLIDE LIGNOCERATE, LIPOSOME THEREOF AND PREPARATION METHOD THEREFOR
#96CORONAVIRUS VACCINE
#97METHODS AND COMPOSITIONS FOR USING PLASMA CELL DEPLETING AGENTS AND/OR B CELL DEPLETING AGENTS TO SUPPRESS HOST ANTI-AAV ANTIBODY RESPONSE AND ENABLE AAV TRANSDUCTION AND RE-DOSING
#98NANOALUM PARTICLES CONTAINING A PEGYLATED LIPID SIZING AGENT
#99PEGYLATED LIPOSOMES AND METHODS OF USE
#100CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#101PEG-LIPIDS AND LIPID NANOPARTICLES
#102COMPOSITIONS AND METHODS OF THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS
#103GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF
#104ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF
#105A COMPOSITION COMPRISING LIPID NANOPARTICLES AND AN ANTIFUNGAL POLYENE
#106SULFIDE-CONTAINING IONIZABLE LIPID AND LIPID NANOPARTICLE INCLUDING THE SAME
#107LIPID NANOPARTICLE COMPOSITION COMPRISING GALLIC ACID DERIVATIVE LIPID AND USE THEREOF
#108MRNAS ENCODING CHECKPOINT CANCER VACCINES AND USES THEREOF
#109ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF
#110ALPHA POLYGLUTAMATED PRALATREXATE AND USES THEREOF
#111GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF
#112LIPOSOMAL COMPOSITIONS
#113HEMOSTATIC MATERIAL
#114LIPID NANOPARTICLES
#115LNCRNA TRANSCRIPTS IN MELANOMAGENESIS
#116D GLUTAMATE POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#117TREATMENT AND PREVENTION OF CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASES
#118SYNTHETIC PLATELETS
#119METHODS FOR PREPARING AND CHARACTERIZING ZEIN-FUCOIDAN CONJUGATED NANO-LIPOSOME FOR PHYTOL ENCAPSULATION
#120LIPID NANOPARTICLES FOR DELIVERING NUCLEIC ACID TO PERIPHERAL BLOOD MONONUCLEAR CELLS, AND METHOD FOR DELIVERING NUCLEIC ACID TO PERIPHERAL BLOOD MONONUCLEAR CELLS USING SAME
#121COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES
#122PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
#123RNA MOLECULES AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
#124TARGETED LIPOSOMAL GEMCITABINE AND METHODS THEREOF
#125A DRUG NANOCARRIER SYSTEM TO DELIVER A COMBINATION OF TLR AGONISTS AND/OR A LIPOXIN PLUS IMMUNOGENIC CELL DEATH INDUCING CHEMOTHERAPEUTIC AGENTS FOR CANCER IMMUNOTHERAPY
#126LIPOSOME COMPOSITION AND LIPOSOME-CONTAINING PHARMACEUTICAL COMPOSITION
#127TRIPLEX NANOPARTICLES
#128COLLOIDAL PARTICLES FOR USE IN MEDICINE
#129NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF
#130IONIZABLE CATIONIC LIPIDS
#131LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS
#132ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#133Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle
#134Lipid Nanoparticle Compositions and Methods for mRNA Delivery
#135EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA
#136Stabilizing Camptothecin Pharmaceutical Compositions
#137METHOD FOR PREPARING LIPOSOMES
#138PLATINUM COMPLEXES AND USES THEREOF
#139LIPIDS AND LIPID NANOPARTICLE FORMULATIONS
#140STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS
#141LIPOSOMES CONTAINING PHOSPHORYLATED TAU PEPTIDES FOR INDUCING SUSTAINED IMMUNE RESPONSES
#142LIPIDS AND LIPID NANOPARTICLE FORMULATIONS
#143METHOD FOR CARTILAGE REGENERATION AND REGROWTH FOLLOWING INJURY
#144LIPOSOME COMPOSITIONS COMPRISING WEAK ACID DRUGS AND USES THEREOF
#145COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
#146CONCATEMERIC PEPTIDE EPITOPE RNAS
#147STABILIZED LIPID NANOPARTICLE MRNA COMPOSITIONS AND USES THEREOF
#148GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#149NUCLEIC ACID-LIPID NANOPARTICLE AND METHOD USING THE SAME
#150IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY
#151LIPID NANOPARTICLES
#152CRISPR-MEDIATED HUMAN GENOME EDITING WITH VECTORS
#153Lipid Nanoparticle Compositions and Methods for mRNA Delivery
#154LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION
#155POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#156ULTRASOUND-RESPONSIVE LIPOSOME NANOPARTICLES AND PREPARATION METHOD AND USE THEREOF
#157MRNA VACCINE
#158CORONAVIRUS VACCINE
#159IONIZABLE LIPIDS, LIPID NANOPARTICLES, AND USES THEREOF
#160COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS
#161LIPID COMPOUND AND PREPARATION METHOD THEREFOR, AND USE THEREOF
#162CELL-WALL BINDING PROTEIN SPECIFICALLY TARGETING CUTIBACTERIUM ACNES
#163Neurosome/Astrosome Compositions and Methods of Use
#164ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF
#165CATIONIC LIPID COMPOUND, COMPOSITION CONTAINING SAME AND USE THEREOF
#166GAMMA POLYGLUTAMATED PRALATREXATE AND USES THEREOF
#167MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
#168IONIZABLE DISULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM
#169LIPOSOME ENCAPSULATED AFFINITY DRUG
#170MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO
#171OXAZOLIDINONE LIPOSOME COMPOSITIONS
#172MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A
#173GAMMA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#174EXOSOME, METHOD OF FORMING SAME, AND COMPOSITION CONTAINING SAME
#175LIPID-BASED COATING COMPOSITION, AND AN OBJECT HAVING A LIPID-BASED COATING
#176COMPOSITION COMPRISING HYBRID EXOSOME
#177LIPIDS FOR DRUG DELIVERY, NANOPARTICLES COMPRISING SAME, AND COMPOSITION FOR DRUG DELIVERY COMPRISING NANOPARTICLES
#178NANOPARTICULATE FORMULATION
#179HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER
#180COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF
#181VARICELLA ZOSTER VIRUS (VZV) VACCINE
#182POLYNUCLEOTIDES ENCODING INTEGRIN BETA-6 AND METHODS OF USE THEREOF
#183COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE
#184SYSTEMS FOR TREATING PULMONARY INFECTIONS
#185CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6 EXPRESSING CANCER
#186MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#187ALPHA AND GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#188LIPOSOMAL FORMULATIONS OF CORTICOSTEROIDS AND USES THEREOF
#189POLYNUCLEOTIDES ENCODING RELAXIN FOR THE TREATMENT OF FIBROSIS AND/OR CARDIOVASCULAR DISEASE
#190CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS
#191Peptide Conjugated Particles
#192CATIONIC LIPID-BASED NANOCARRIER AND PREPARATION METHOD AND APPLICATION THEREOF
#193PLASMA COATING METHOD OF NANOVESICLE SURFACE AND PLASMA JET DEVICE FOR PLASMA COATING OF NANOVESICLE SURFACE
#194LIPID COMPOUND, LIPOSOME, EXOSOME, LIPID NANOPARTICLE, AND DRUG DELIVERY SYSTEM
#195DEVELOPMENT OF A NEW FAMILY OF NANOCARRIERS DERIVED FROM NATURAL TETRAMERIC ACID LIPIDS
#196Stabilizing Camptothecin Pharmaceutical Compositions
#197OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF
#198OXAZOLIDINONE COMPOUNDS, LIPOSOME COMPOSITIONS COMPRISING OXAZOLIDINONE COMPOUNDS AND METHOD OF USE THEREOF
#199IONIZABLE CATIONIC LIPIDS
#200REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES
#201IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER
#202MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
#203NANOPARTICULATE MONOBENZONE FOR TREATING MELANOMA
#204NUCLEIC ACID VACCINES
#205Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle
#206LIPOSOMAL COMPOSITIONS AND METHODS OF USE THEREOF FOR IMPROVED STABILITY, BIOAVAILABILITY & SUSTAINED RELEASE
#207INTRAARTICULAR POSTEROMEDIAL LANDMARK INJECTION FOR LOWER EXTREMITY ANALGESIA
#208NUCLEIC ACID VACCINES
#209NUCLEIC ACID VACCINES
#210RNA CONSTRUCTS AND USES THEREOF
#211POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#212RNA FORMULATIONS AND LIPIDS
#213Nucleic acid vaccines
#214LIPOSOMAL COMPOSITIONS AND USES OF SAME
#215DRUG-LOADED LIPOSOMES AND USES THEREOF IN TREATING BIOFILM
#216LIPOCOACERVATES AND METHODS OF MAKING AND USING SAME
#217IONIZABLE CATIONIC LIPIDS
#218PAN-HUMAN CORONAVIRUS VACCINES
#219LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF
#220Immunomodulatory Combinations of Antigen and Drug-Lipid Conjugate
#221PROTEOLIPID VESICLES FORMULATED WITH FUSION ASSOCIATED SMALL TRANSMEMBRANE PROTEINS
#222SELF DEGRADATION-TYPE CDK9 INHIBITOR PRODRUG AND LIPOSOME ENCAPSULATING SAME
#223TROPICAL DISEASE VACCINES
#224INTERLEUKIN-12 SELF-REPLICATING RNA AND METHODS
#225MODIFIED COLLOIDAL PARTICLES FOR USE IN THE TREATMENT OF HAEMOPHILIA A
#226HONOKIOL LIPOSOME TRANSDERMAL GEL, PREPARATION METHOD AND USE THEREOF
#227Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
#228Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#229NANOPARTICLES FOR CANCER TREATMENT
#230LONG CYCLE-LIFE WOUND LITHIUM-ION BATTERY CELLS HAVING METALLIZED FILM CURRENT COLLECTORS
#231DOUBLE STRANDED MRNA VACCINES
#232METHODS FOR PREPARING LIPOSOMAL FORMULATIONS
#233FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF
#234Liver Specific Delivery of Messenger RNA
#235mRNAS FOR TREATMENT OR PROPHYLAXIS OF LIVER DISEASES
#236Methods For Treating Pancreatic Cancer Using Combination Therapies
#237CYCLOHEXANE LIPIDOIDS FOR NUCLEIC ACID TRANSFECTION AND USE THEREOF
#238NANOPARTICULATE FORMULATION
#239MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#240METHOD FOR ATTENUATING NEUROINFLAMMATION, AMYLOIDOPATHY AND TAUOPATHY
#241AMNIOTIC FLUID STABILIZED COMPOSITIONS AND METHODS FOR IN UTERO DELIVERY OF THERAPEUTIC AGENTS
#242COMPOSITIONS AND METHODS FOR TARGETED RNA DELIVERY
#243COMPOSITIONS COMPRISING HYDROXYETHYL-CAPPED CATIONIC PEPTOIDS
#244IONIZABLE LIPID MOLECULE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF LIPID NANOPARTICLE
#245LIPID NANOPARTICLES AND METHOD FOR PREPARING SAME
#246CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS
#247LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF
#248TREATMENT OF PRIMARY CILIARY DYSKINESIA WITH SYNTHETIC MESSENGER RNA
#249MRNA VACCINES ENCODING FLEXIBLE CORONAVIRUS SPIKE PROTEINS
#250REDUCING HYDROPHOBIC DRUG ADSORPTION IN ECMO CIRCUITS
#251Polynucleotide compositions, related formulations, and methods of use thereof
#252MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS
#253SYSTEMS AND METHODS FOR TARGETED BREAST CANCER THERAPIES
#254SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS
#255DUAL-TARGETING BIOMIMETIC LIPOSOME WITH ELEMENE (ELE) AND CABAZITAXEL (CTX), AND PREPARATION METHOD AND USE THEREOF
#256Cationic lipid compound, composition containing same and use thereof
#257LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID
#258COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS
#259SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE
#260INFLUENZA VIRUS NUCLEIC ACID LIPID PARTICLE VACCINE
#261POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS
#262Compositions and methods of mRNA vaccines against novel coronavirus infection
#263Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
#264METHODS FOR PRODUCING NANOPARTICLE DISPERSIONS
#265Liposome compositions comprising weak acid drugs and uses thereof
#266PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
#267MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA
#268LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING PHENYLALANINE HYDROXYLASE AND USES THEREOF
#269IMMUNE STIMULATING NANOPARTICLE COMPOSITION
#270PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF
#271LIPID NANOPARTICLES AND POLYNUCLEOTIDES ENCODING ORNITHINE TRANSCARBAMYLASE FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
#272PROTEOLIPID VESICLES FORMULATED WITH FUSION ASSOCIATED SMALL TRANSMEMBRANE PROTEINS
#273METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE
#274RED-SHIFTED PHOTOLIPIDS AND NANOPARTICLES FORMED FROM SAME
#275Sterically stabilized carrier compositions for treating a mammal
#276DEVELOPMENT OF COVID-19 VACCINE USING A DUAL TLR LIGAND LIPOSOME ADJUVANT
#277DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
#278NANOTHERAPEUTICS FOR TREATMENT OF SARS-COV-2
#279LIPOSOMAL FORMULATIONS OF BORONIC ACID CONTAINING ACTIVE AGENTS
#280ALPHA POLYGLUTAMATED PEMETREXED AND USES THEREOF
#281LIPOSOME COMPOSITIONS AND METHODS OF USE THEREOF
#282Liposome formulations
#283METHODS OF PREPARATION OF NOVEL PAN TLR ANTAGONISTIC LIPOSOMAL-LNP FORMULATIONS AND USES THEREOF
#284LNP COMPOSITIONS COMPRISING PAYLOADS FOR IN VIVO THERAPY
#285LIPID NANOPARTICLE WITH TARGET INTEGRIN FUNCTION AND USES THEREOF
#286MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS
#287USE OF HIGH MOLECULAR WEIGHT POLYETHYLENE GLYCOL COMPOSITIONS TO RESTORE THE EFFICACY OF PEGYLATED THERAPEUTIC COMPOSITIONS
#288LIPID NANOPARTICLES AND METHODS OF USE THEREOF
#289Compounds and compositions for intracellular delivery of therapeutic agents
#290POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF
#291LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#292MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS
#293HLA-RESTRICTED VCX/Y PEPTIDES AND T CELL RECEPTORS AND USE THEREOF
#294NOVEL CARBONYL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
#295COMPOSITION FOR PENETRATING BLOOD-BRAIN BARRIER, CONTAINING SONOSENSITIVE LIPOSOMES AS ACTIVE INGREDIENTS
#296ENCAPSULATED RNA POLYNUCLEOTIDES AND METHODS OF USE
#297Multiple CEST contrast imaging of nose-to-brain drug delivery using CT-contrast agent-loaded liposomes
#298POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#299ANTI-TUMOR AGENT
#300TREATMENT AGENT